Patents by Inventor Max Stanley Topp

Max Stanley Topp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110086035
    Abstract: A peptide of less than 10 000 molecular weight comprising the amino acid sequence FHTYTI DWTKDAVTW or a portion thereof, or a variant thereof wherein the side chains of one or two of the amino acid residues are altered, wherein the portion or variant is capable of binding HLA-DRB1*04. The peptide, certain polypeptide fusion molecules and certain polynucleotides encoding the same may be useful in combating Aspergillus infection or allergies. In particular, they may be used in processes for preparing Aspergillus-specific T cells for adoptive immunotherapy.
    Type: Application
    Filed: March 11, 2009
    Publication date: April 14, 2011
    Applicant: CELL MEDICA LIMITED
    Inventor: Max Stanley Topp